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Pharmacists and physicians are being increasingly encouraged to adopt a collaborative approach 
to patient care, and delivery of health services. Strong collaboration between pharmacists and 
physicians is known to improve patient safety, however pharmacists have expressed difficulty in 
developing interprofessional working relationships. There is not a significant body of knowledge 
around how relationships influence how and when pharmacists and physicians communicate 
about patient care.  
 
Objectives 
This paper examines how pharmacists and primary care physicians communicate with each 
other, specifically when they have or do not have an established relationship 
 
Methods 
Thematic analysis of data from semi-structured interviews with nine primary care physicians and 
25 pharmacists, we examined how pharmacists and physicians talk about their roles and 
responsibilities in primary care and how they build relationships with each other.  
 
Results 
We found that both groups of professionals communicated with each other in relation to the 
perceived scope of their practice and roles. Three emerging themes emerged in the data focusing 
on (1) the different ways physicians communicate with pharmacists; (2) insights into barriers 
discussed by pharmacists; and (3) how relationships shape collaboration and interactions. 
Pharmacists were also responsible for initiating the relationship as they relied on it more than the 
physicians. The presence or absence of a personal connection dramatically impacts how 
comfortable healthcare professionals are with collaboration around care. 
 
Conclusion 
The findings support and extend the existing literature on pharmacist-physician collaboration, as 
it relates to trust, relationship, and role. The importance of strong communication is noted, as is 


















Communication between healthcare professionals on a healthcare team is foundational to patient 2 
care; however, often the only communication occurring is through fax, or other non-collaborative 3 
tools. Physician and pharmacists share a similar training history, as well as shared values and 4 
norms, but each profession has unique sub-cultures and characteristics.1,2 There is strong 5 
research on the benefits of pharmacist-physician collaboration, such as enhanced quality of care, 6 
increased patient engagement, improved patient safety, s well as staff satisfaction and retention, 7 
and greater staff perceptions of empowerment and recognition all of which fall under the practice 8 
of interprofessional collaboration.3–6 Strong working relationships between physicians and 9 
pharmacists are foundational to providing good patient care.7–9 The implication of robust 10 
communication between physicians and pharmacists is an mportant foundation upon which to 11 
base interprofessional trust.  12 
The ways in which pharmacist-physician relationship influence communication have not been 13 
widely explored. Existing research emphasizes the community pharmacist’s roles of drug 14 
dispensing, medication therapy management, chronic disease management, and patient 15 
education.10,11 The degree of collaboration between individual physicians and pharmacists varies 16 
greatly, and is dependent on a number of influential factors such as shared values, relationships, 17 
role definition, and trust.3,12 For patients, an effective collaboration by their healthcare team can 18 
lead to improved coordination with healthcare professionals (HCPs), increased opportunity to 19 
participate in decision-making, improved satisfaction and better use of resources.13–16 Challenges 20 
to collaboration are the lack of compensation for teamwork, limited time, and the necessity to 21 
coordinate care across many different practitioners.2  22 
Traditionally, community pharmacists and physicians have worked in separate locations with 23 
little face-to-face contact. Team-based primary care, lso known as the medical home or family 24 
health team, is one of the models for providing more integrated community health care, where 25 
the physician works in a co-located setting with oter HCPs such as nurse practitioners, nurses, 26 
and pharmacists.17 Notably, the pharmacist role is not typically affiliated with a separate drug 27 















healthcare spending..18,19 As new models emerge, more research is needed to understand the 29 
influence of co-location on collaboration.  30 
Our paper begins to address the gap in understanding of how pharmacists and physicians 31 
describe their relationships, both in team-based and traditional settings. Analyzing qualitative 32 
semi-structured interviews with 9 physicians and 25 pharmacists who are and are not co-located, 33 
we examined (a) how and when physicians and pharmacists communicate, (b) how and if 34 
pharmacists and physicians discuss personal relationships, (c) what are the barriers to 35 
communication between them, and (d) how and if co-location changes their relationship.  36 
Methods 37 
Study Design 38 
This research is based on thematic qualitative analysis of semi-structured interviews. The 39 
investigators were gathering the subjective experiences of pharmacists and physicians to better 40 
understand the meaning they attach to their experiences interacting with each other. This paper is 41 
part of a larger study of how physicians, pharmacists, and patients understand and communicate 42 
patient-focused medication information to each other.(anon) We chose a qualitative Focused 43 
Ethnographic approach to capture experiences in the socio-cultural context in which participants 44 
interact with each other.20 Focused ethnography is an evolving method used primarily in 45 
practice-based disciplines to, as Hall describes, “…capture specific cultural perspectives and to 46 
make practical use of that understanding.”21 Focused ethnography most commonly uses 47 
purposive sampling techniques and allows for a holistic exploration of a research question that 48 
may adapt as the research occurs.20  49 
Ethics approval was received from the University of Waterloo, University of Alberta, Wilfrid 50 
Laurier University, Université Laval, University ofToronto, and Dalhousie University. A 51 
qualitative methodological approach of semi-structured interviews, talk-alouds, and observations 52 
was carried out with nine primary care physicians (PCP) and 25 pharmacists across Canada, 53 
allowing for open sharing of views on how medication-related decisions are made and 54 
communicated both across professions and to patients.  55 















Recruitment was conducted through advertisement in public venues (e.g., libraries, community 57 
centers) and posting on social media sites (Facebook, Twitter), and through snowball sampling 58 
from previous and existing contacts of the research team, professional outreach, and suggestions 59 
from participants resulting in a convenience sample. Participants were included if they were: (1) 60 
a licensed and practicing pharmacist or physician; (2) spoke English or French; (3) lived and 61 
worked in Nova Scotia, Quebec, Ontario, or Alberta. P rticipants were recruited to include a 62 
range of perspectives, experiences, years of practice, and geographical location, with our sample 63 
providing a good balance of team and independence practice pharmacists and physicians (Table 64 
1). Identified participants fell into two categories (1) team-based, where pharmacists and 65 
physicians were co-located and practicing together; (2) independent practice, which may include 66 
both clinics as well as corporate practices, where they were not co-located but may work closely 67 
depending on environmental factors including size of community and established working 68 
relationships. Participants were diverse and included ifferent years in practice, age, and gender. 69 
All participants were provided with a letter of information and gave their consent to voluntarily 70 
take part in the study. 71 
In total, three research assistants conducted and audio recorded the interviews. Initial interviews 72 
were jointly conducted to train student research assistants in semi-structured interviewing 73 
techniques, and regular meetings were scheduled to compare notes, go over interviews and 74 
discuss emerging results. Field notes were recorded during and after the interviews. 75 
Data Analysis 76 
Although the interviews primarily explored how physicians and pharmacists make medication 77 
related decisions, insights into how relationships influence the ways in which physicians and 78 
pharmacists communicate emerged. Analysis was largely inductive, and used a modified form of 79 
constant comparative analysis the data was analyzed until theoretical saturation was reached. 22–80 
24 The majority of the analysis came from the interviw transcripts with some triangulation 81 
coming from talk-alouds, observations, and field notes. Initially the coding was done in two parts 82 
– first with a small group analyzing the interviews using “free” unstructured coding and largely 83 
descriptive codes, and then, during a two-day meeting, he Framework Method was used to bring 84 















researchers (5), business and communication researcher (1), patients (2), and a patient navigator 86 
(2) to develop the codes used for the analysis of the two prior papers.25,26 From the initial 87 
analysis two papers emerged, one about patient medication decision-making, and another on 88 
pharmacists and physician decision-making.(27,28) After these two papers were completed, the 89 
authors determined the value of further analyzing the interviews to specifically. Initial re-90 
analysis of the data was completed by KM, who listened again to the interviews, coded the data, 91 
and defined preliminary themes. Next the authors completed a secondary analysis of the 92 
collected interview data (KG,LG,CB,KG), who participated in all phases of the original coding 93 
and analysis, and one member who was brought in as a final coder (EN). Data were stored, 94 
organized, and reported using QSR NVIVO 11 Software (QSR International Pty Ltd. Version 11, 95 
2017).  96 
In what follows, we examine the process of how personal relationships between pharmacists and 97 
physicians impact how they discuss collaboration and professional interaction. Comparing the 98 
accounts of physicians, and pharmacists allows us to explore the interactions, what was and was 99 
not said, and how each professional understands the role of the other. Multiple triangulation of 100 
the data was achieved through a multi-disciplinary team of researchers interpreting the results, 101 
multiple coders, and by conducting interviews across Canada in a variety of different settings.29 102 
Results 103 
In total, 34 semi-structured interviews were conducted with physicians and pharmacists across 104 
Canada using an interview guide (see Appendix 1). The interviews were conducted at a place of 105 
the participants choosing, most commonly their place of work, and took between 30 minutes and 106 
one hour to complete, depending on participant avail bility. Table 1 summarizes individual and 107 
contextual characteristics of pharmacists and physicians obtained from the demographic survey. 108 
The participants represented both urban and rural environments from across Canada, specifically 109 
in the provinces of Alberta, Ontario, Quebec, and Nova Scotia.  110 
The results of this secondary analysis are presented i  this paper. The secondary analysis resulted 111 
in three new thematic areas, different from the original paper focused on understanding how 112 
relationships and collaborations are discussed.28 “My pharmacist” examines when physicians 113 















examples of when they sought out a pharmacist with hom they had a relationship. “Can’t get 115 
through to them” gives data on barriers discussed by pharmacists, namely the different 116 
perceptions of gatekeepers and modes of easy communicatio . Finally, “It took a little bit of 117 
time” discusses when relationships have been built, positively or negatively, and how this shapes 118 
collaboration and interactions. 119 
“My pharmacist” 120 
During the interviews, physicians and pharmacists were asked how and when they 121 
communicated with each other. All physician respondents spoke about pharmacists affirmatively, 122 
but there was a marked difference in how physicians spoke about their communication with 123 
pharmacists in general and those with whom they have a confident working relationship or 124 
worked with as part of a team. The participating physicians attributed positive relationships with 125 
pharmacists to being located close by, or to co-locati n as part of a team based clinic, and 126 
separated pharmacists they knew from pharmacists they did not know: 127 
“I called the pharmacy because I wasn’t sure how to prescribe some 128 
medication… In fact, a pharmacist answered and I asked if [D] was there 129 
because I know him, and I spoke to him.” [Physician 1201, Team 130 
Environment, Ontario] 131 
When responding to an interview question about what sort of interactions the physician has with 132 
pharmacists, Physician 1207 stated, “That’s our pharmacist.” During Physician 1205’s 133 
interview when discussing if they worked together with pharmacists in patient care, 1205 replied 134 
that “… Individuals that I feel could benefit from a med reconciliation, I would refer them to B, 135 
my pharmacist.” Physicians who spoke about ‘their’ pharmacist in th s way of ‘knowing them,’ 136 
thusly identified their pharmacist as smart and reliable.  137 
For physicians who did not work in the same building, or very close to pharmacists, the level of 138 
collaboration was markedly different.  139 
“My patients all have different pharmacies… I rarely speak to the same 140 















team work but rather sporadic interactions... We don’t have direct contact to 142 
create therapeutic plans” [Physician 1209, Team Environment, Quebec]  143 
Physician 1209 specifically mentioned that they do not want to ‘waste’ time establishing the 144 
basics of a relationship when they do not know if they will ever speak to that pharmacist again.  145 
In contrast, when physicians mentioned having a specific pharmacist they talk to, they often 146 
described having trust or confidence in the pharmacist: 147 
“With the pharmacist we have in our department, for su e, we are very 148 
spoiled… I have complete confidence in her skills… So, with my pharmacist, 149 
everything works very well. And I have no problem with her making 150 
suggestions.” [Physician 1210, Team Environment, Quebec]  151 
Comparatively, the quote below demonstrates the othr way of discussing interactions with 152 
pharmacists, more common to physicians not actively working in collaborative environments.  153 
“I would message the front and ask them to call the p armacy and confirm… 154 
unless there’s a bigger concern I’m happy for the secretaries to do it.” 155 
[Physician 1203, Team Environment, Ontario] 156 
For physicians who do wish to develop a relationship with a pharmacist, the evolving corporate 157 
model of pharmacy can be a barrier to relationship building: 158 
[I know pharmacists at] maybe a half dozen pharmacies. For the other 28, I 159 
don’t know who I’m speaking to… [Pharmacist] is like the old-time, country, 160 
family pharmacists. He knows his patients, and he’sthere all the time. 161 
[Pharmacists at big chains] they just come and go, and you never know who’s 162 
there next. They don’t know the patients… it’s challenging. [Physician 1201, 163 
Team Environment, Ontario] 164 
The above physician demonstrates their perception of the difference between pharmacists they 165 
know and feel comfortable with versus ones they do not know. The idea that the unknown 166 
pharmacist would also not know the shared patient is key to understanding the difficulties in 167 















pharmacist relies on the patient being familiar to the pharmacist. Physician 1205 noted that they 169 
appreciated the respectfulness of the pharmacist they work with most often, and was clear that 170 
part of that respect included the physician having the final say: 171 
“I found [B] to be extremely respectful, and oftentimes like I said at this stage 172 
we’re still in the “These are my suggestions,” and I still have the okay or not 173 
okay” [Physician 1205, Team Environment, Ontario] 174 
This physician’s sense of it being unimportant for them to have an interaction with an unknown 175 
pharmacist to clarify information directly contradicts Physician 1201, who feels ‘spoiled’ to have 176 
full confidence in their pharmacist’s skills.  177 
As a counter to physicians who most often could identify a single pharmacist, the pharmacists 178 
who are not co-located and by necessity interact with a wider group of physicians as such have to 179 
navigate unfamiliar physicians as part of their profession. Instead of saying my physician, they 180 
used phrases such as the doctor, a physician, or our clinic. The difference in the language used to 181 
describe relationships between physicians and pharmacists also comes through in how both 182 
pharmacists and physicians discuss interprofessional c mmunication.  183 
 “Can’t get through to them” 184 
Pharmacists identified that they can be more effectiv  when they have a strong relationship with 185 
the physician. However, it was very challenging for pharmacists to initiate a relationship with a 186 
physician. Gatekeepers, often reception staff or nurses, were mentioned as barriers to direct 187 
communication with physicians, especially in independ nt pharmacy settings: 188 
“[Family Doctors], you can’t get through to them. There’s the ward clerk who 189 
won’t let you through to the doctor. It’s really difficult to get the doctor on the 190 
phone unless they’re calling you.” [Pharmacist 1102, Independent Practice, 191 
Ontario]  192 
This said, even in situations where there was a dedicated phone line, there were still barriers to 193 















“Either it’ll be the secretary running back and forth between me and the doctor, if they 195 
say that the doctor can’t come to the phone. In that case, they’ll just ask me to fax it.” 196 
[Pharmacist 1105, Independent Practice, Ontario] 197 
The exception was in rural practice, where pharmacists were more likely to meet physicians 198 
through small social networks, because there were few r providers in town, or because the clinic 199 
and pharmacy were closer together. During the interviews, it became clear that co-location 200 
allows for the same type of informal networking and rapport building as rural environments. 201 
Pharmacists who identified relationships with specific physicians outside of a co-located 202 
environment were more likely to mention the ability to call a physician to discuss a patient:  203 
“If it's urgent, I will call them. I have most of the local doctor's cell phone 204 
numbers. If I need to get a hold of them, I will get a hold of them.” 205 
[Pharmacist, 1101, Independent Practice, Ontario] 206 
This pharmacist goes on later to discuss how having a relationship with a physician eases the 207 
process of communication: “I have an arrangement with the doc to just call him if there’s a 208 
major issue and we fix it now.” 209 
In contrast, every physician mentioned it was easy to contact a pharmacist if needed:  210 
“If the patient’s in the office, I will call the pharmacist right then and there… I 211 
will talk to the pharmacist and we’ll try and resolve it.” [Physician 1206, 212 
Team Environment, Alberta]  213 
Most physicians interviewed agreed with the pharmacists that fax as the easiest way to 214 
communicate. While the pharmacists saw fax as a way to have a record of the conversation, less 215 
intrusive, or as an easier mode of communication for the physician, physicians said that they 216 
preferred fax as a way to align patient care, rathe t an to seek out clarifications or collaborate.  217 
“I'll usually do a fax just because I feel like it's less intrusive, and so they can 218 
potentially get back to me quicker without having to call, but if it's something 219 
that I really want to know, then I might do both.” [Pharmacist 1107, 220 















The lack of easy communication outside of co-location settings was an issue for both physicians 222 
and pharmacists. Physician 1201 ended their comment by stating that having direct conversations 223 
with pharmacists would be more productive than “…waiting for this stuff to sort itself out.” 224 
Physicians in team-based environments described stronge  relationships with community 225 
pharmacists who were not co-located, suggesting when p ysicians work closely with pharmacists 226 
they gain a better understanding of the role pharmacists have in health: 227 
“We know most of our pharmacists that are in the neighbourhood and we have 228 
a good rapport with them, and we can phone them up, we’ve met them. We talk 229 
to them because they’re physically within walking distance” [Physician 1208, 230 
Team Environment, Ontario]  231 
Having a good rapport with pharmacists based on physical walking distance also implies that the 232 
physician has a strong community focus and that the physician and pharmacist are working 233 
together to support patients, the community, and each other.  234 
 “It took a little bit of time” 235 
As the team-based model grows in popularity and is increasingly seen as an ideal way to care for 236 
patients, there was a general feeling that collaborting with known colleagues was preferred, 237 
though it takes time to develop the relationship. 238 
“It took a little bit of time for the doctors to feel comfortable with me, to be 239 
able to realize what my skillset was” [Pharmacist 1118, Team Environment. 240 
Ontario]  241 
Pharmacists noted a stronger sense of agency when working in co-located environments, feeling 242 
more positive about the overall influence they have o r care. Developing relationships between 243 
practitioners was built around an awareness of role and ability.  244 
“I was the only pharmacist here so I had to essentially develop my own role, which is 245 
great because I had a lot of autonomy. It was also challenging too because the 246 















pharmacist role in a family health team.” [Pharmacist 1118, Team 248 
Environment, Ontario] 249 
But over time, the pharmacists became a central part of the team, relied upon in the daily 250 
workflow.  251 
“I work with a team of family physicians. We are about 24 physicians. We 252 
have a pharmacist. If ever [the pharmacist] is not there because there is a day 253 
of the week she is not, then at that moment, if it isn’ urgent, I’ll wait until she 254 
is back at work the next day.” [Physician 1210, Team Environment, Quebec]  255 
Negotiating boundaries around care and role can be difficult. When pharmacists have not worked 256 
in collaborative partnerships, even in team-based clinics, they identified difficulty articulating 257 
the boundaries of their role and emphasized they only asserted themselves with physicians they 258 
knew,  259 
“[Giving recommendations] is not so much with physicians outside of the 260 
clinic where I work. It’s specifically with the ones I collaborate with at the 261 
community health center clinic.” [Pharmacist 1124, Team Environment, 262 
Ontario] 263 
When relationship building has been successful, the benefit of casual interactions becomes 264 
apparent. During Pharmacist 1118’s workflow talk-aloud, the process was interrupted by a 265 
physician interrupting the think-aloud to say hello, seeing if the pharmacist was available to talk 266 
about shared patients. 267 
“Physician: I just wanted to poke in and say Hi, but I will let you guys do your thing. 268 
Pharmacist 1118: Yeah, no problem 269 
Physician: [After you’re done] we can go over to the café and maybe get some tea or 270 
coffee or something.” 271 
These informal interactions are only possible when there is a personal relationship between 272 
practitioners. Later in the think-aloud Pharmacist 1118 discussed how personal relationships 273 















doctors here, I can just send them a message saying, "Hey, can you do this blood work for me?"” 275 
Interestingly, this played out in Pharmacist 1118’s perception of the expanded scope of practice 276 
as well:  277 
“I don't really need to practice under the expanded scope because I have such 278 
a good relationship and such close contact that I don't necessarily need to 279 
write a prescription or extend a prescription because I can just say, "Hey, can 280 
you just do that for me?"” .” [Pharmacist 1118, Team Environment, Ontario] 281 
Physicians who did not work directly with pharmacists in co-located settings discussed that 282 
while they did interact with pharmacists, in most cases those interactions were limited to 283 
clarifications. The noted examples of collaboration between physicians and pharmacists only 284 
occurred in situations when there was an established relationship where they either knew each 285 
other personally or worked together in a collaborative health environment.  286 
 Discussion 287 
The original purpose of gathering this data used for this analysis was to better understand the 288 
decision-making process by physicians and pharmacists.30 Our analysis identified that co-289 
location allows relationship building through familiarity and ease of access, both of which allow 290 
the pharmacist to demonstrate their expertise.  This qualitative exploration of how relationships, 291 
trust, and communication are discussed often included mentions and clarifications of role, which 292 
is reflective from past research into interprofessional collaboration and provides opportunity for 293 
future study.2,31 294 
During early analysis it emerged that as decisions were being made the influence of personal 295 
relationships between physicians and pharmacists was present as a factor even when the intent of 296 
the interviews was not to investigate these relationships explicitly. The question arose about how 297 
this perception of relationship influences how and when collaboration occurs.  298 
While this study did not measure trust, it is an established factor in building collaborative 299 
relationships.32 Pharmacists who have built established relationships with physicians have more 300 
opportunities to demonstrate their clinical knowledg , which allows physicians to develop trust 301 















As trust builds, our research agrees with what Zillich et al. discussed as being influential to 303 
collaborative relationships: when pharmacists gain co fidence to assert themselves as true 304 
collaborators in care, there is a better understanding the pharmacist’s scope of practice, and 305 
physicians are more likely to initiate interactions and seek out pharmacist expertise.33  306 
Closely linked to ideas around trust are perceptions of role boundaries, and ideas of who is the 307 
ultimate authority on care. Brock et.al discuss how c llaboration between pharmacists and 308 
physicians is influenced by what types of exchange occurs between them.32 The pharmacists and 309 
physicians in this study often identify their role, or their scope of practice, both real and how it is310 
perceived, as influencers in the type of exchange that occurs between each group.31,32 Each time 311 
role, or scope of practice was discussed there was congruence around how physicians and 312 
pharmacists perceived these, even when the perception was not tied to the actual scope of 313 
practice.  314 
Pharmacists discussed being respectful in how they c allenged physicians on questions around 315 
medication management, and physicians who discussed pharmacists positively also cited the idea 316 
of being respectful as a positive driver of good relationships. Within the specific relationships 317 
examined from the physician perspective, working in a co-located environment did not 318 
necessarily result in stronger relationships with pharmacists, however through providing an 319 
opportunity for better communication, it thusly increased collaboration.  320 
Meaningful collaboration occurred when each practitioner actively sought the other out for more 321 
than a back-and-forth interaction.34 Research outside of health care, in marketing and s les, 322 
supports that team cohesiveness is linked to effectiveness, even when it is not connected directly 323 
to improved productivity.35,36 Our results mirror this, in that when pharmacists and physicians 324 
are co-located, or work closely together, the way in which they discuss collaboration shifts from 325 
describing it in more tentative terms, to a more natural interaction. There is very little research 326 
that compares how collaboration changes between practitioners who are directly in a co-located 327 
practices or have an established relationship, versus collaborators who are external to the 328 
practice.  329 
Within the relationships discussed, it was clear tht having a personal relationship with a specific 330 















to them having a clearer understanding of the pharmacist role in patient care, and feeling that 332 
care is shared between them. Similar to Snyder et al.’s study, we found that generally 333 
pharmacists were the primary initiator or relations, and described their process to building 334 
relationships with physicians clearly.31 The pharmacists who operated in co-located 335 
environments or within ‘walking distance’ of a physician were more likely to described 336 
successfully relationship building, and often describing that there were shared motivators, such 337 
as improving patient care.33 Still, physicians were the gatekeepers of the relationship.37 338 
Limitations 339 
This study reached saturation, however, there was a relatively low response rate for physicians, 340 
with less than half the number of physicians responding than pharmacists. Our sample was a 341 
convenience sample, and the participants who were willing to share their views may have had 342 
different attitudes and experiences than pharmacists and physicians that were not interested in 343 
the research.  Our data was triangulated through the in erviews and talk-alouds, and through 344 
coding, saturation was reached. Future studies can in lude participants that identify as high 345 
collaborators, as well as those who do not collaborte on a regular basis.  346 
Conclusions 347 
Strong pharmacist and physician working relationship  not only influence how and when 348 
collaboration happens but also influence the level to which collaboration occurs. The findings 349 
from this study demonstrate that while physicians who have an established relationship with a 350 
specific pharmacist hold positive perceptions around a pharmacist’s role, this does not 351 
necessarily transfer to other pharmacists as professi nals. This analysis focused on identifying 352 
the differences physicians and pharmacists discuss in communicating with known, versus 353 
unknown colleagues, and understanding barriers to succe sful collaboration 354 
Understanding of different working environments where ach player feels able to best use their 355 
skills and collaborate to improve patient care is important. Different environments support 356 
nuanced approaches to collaborative care. The role relationships have in influencing how and 357 















collaborative care teams.  Carefully designing system  that support active collaboration as well 359 
as ways of communicating is important to ensure strong interprofessional partnerships.  360 
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Table 1. Participant demographics collected at the time of interview (n=34)(20)  
 Family Physicians (N=9) Pharmacists (N=25) 
Total Participants 9 25 
 Team Environment 5 4 
 Independent Practice 4 21 
Urban  9 18 
Rural 0 7 
Years in Practice 12.6 16.2 
Average time in current practice (years) 9.9 7.1 
Average Age (years) 43.4  39.8  
 25-35 years old 2 7 
 36-45 years old 4 12 
 46-55 years old 2 4 
 55+ years old 1 2 
Gender 
 Male 4 11 
 Female 5 14 
 
 
